Journal
BLOOD PRESSURE MONITORING
Volume 20, Issue 1, Pages 52-55Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MBP.0000000000000086
Keywords
blood pressure measurement; British Hypertension Society; International Organization for Standardization; low-resource setting; oscillometric; pre-eclampsia; pregnancy; validation; WHO
Categories
Funding
- Bill & Melinda Gates Foundation
- Maternity Worldwide
- MRC [MR/N006240/1] Funding Source: UKRI
- Medical Research Council [MR/N006240/1] Funding Source: researchfish
- National Institute for Health Research [RP-2014-05-019, ACF-2009-17-019, DRF-2013-06-171] Funding Source: researchfish
Ask authors/readers for more resources
Objectives To assess the accuracy of the Microlife 3AS1-2 blood pressure device in pregnancy and pre-eclampsia in a low-resource setting. Methods Prospective validation according to the British Hypertension Society protocol. A total of 45 pregnant women were recruited from Kimberley Hospital (South Africa), of whom 15 had pre-eclampsia. Results The Microlife 3AS1-2 device achieved an overall B/A grade in pregnancy (including pre-eclampsia), passing the British Hypertension Society protocol requirements and achieving the International Organization for Standardization standard with a mean difference and SD of -3.8 +/- 7.3 and -1.5 +/- 6.2 mmHg for systolic and diastolic pressures, respectively. Conclusion The Microlife 3AS1-2 device can be recommended for use in pregnancy, including pre-eclampsia. In addition, it fulfils the requirements stipulated by the WHO for an automated blood pressure device suitable for use in a low-resource setting. This makes it the ideal device for antenatal clinics and primary healthcare facilities in low-income and middle-income countries. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available